202 related articles for article (PubMed ID: 35681212)
1. Detection of ovarian cancer using plasma cell-free DNA methylomes.
Lu H; Liu Y; Wang J; Fu S; Wang L; Huang C; Li J; Xie L; Wang D; Li D; Zhou H; Rao Q
Clin Epigenetics; 2022 Jun; 14(1):74. PubMed ID: 35681212
[TBL] [Abstract][Full Text] [Related]
2. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
Liang L; Zhang Y; Li C; Liao Y; Wang G; Xu J; Li Y; Yuan G; Sun Y; Zhang R; Li X; Nian W; Zhao J; Zhang Y; Zhu X; Wen X; Cai S; Li N; Wu L
EBioMedicine; 2022 Sep; 83():104222. PubMed ID: 35973389
[TBL] [Abstract][Full Text] [Related]
3. Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
Nuzzo PV; Berchuck JE; Korthauer K; Spisak S; Nassar AH; Abou Alaiwi S; Chakravarthy A; Shen SY; Bakouny Z; Boccardo F; Steinharter J; Bouchard G; Curran CR; Pan W; Baca SC; Seo JH; Lee GM; Michaelson MD; Chang SL; Waikar SS; Sonpavde G; Irizarry RA; Pomerantz M; De Carvalho DD; Choueiri TK; Freedman ML
Nat Med; 2020 Jul; 26(7):1041-1043. PubMed ID: 32572266
[TBL] [Abstract][Full Text] [Related]
4. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
[TBL] [Abstract][Full Text] [Related]
5. The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer.
Widschwendter M; Zikan M; Wahl B; Lempiäinen H; Paprotka T; Evans I; Jones A; Ghazali S; Reisel D; Eichner J; Rujan T; Yang Z; Teschendorff AE; Ryan A; Cibula D; Menon U; Wittenberger T
Genome Med; 2017 Dec; 9(1):116. PubMed ID: 29268796
[TBL] [Abstract][Full Text] [Related]
6. Preparation of cfMeDIP-seq libraries for methylome profiling of plasma cell-free DNA.
Shen SY; Burgener JM; Bratman SV; De Carvalho DD
Nat Protoc; 2019 Oct; 14(10):2749-2780. PubMed ID: 31471598
[TBL] [Abstract][Full Text] [Related]
7. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
Terp SK; Stoico MP; Dybkær K; Pedersen IS
Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer detection by DNA methylation in cervical scrapings.
Wu TI; Huang RL; Su PH; Mao SP; Wu CH; Lai HC
Clin Epigenetics; 2019 Nov; 11(1):166. PubMed ID: 31775891
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma.
Lasseter K; Nassar AH; Hamieh L; Berchuck JE; Nuzzo PV; Korthauer K; Shinagare AB; Ogorek B; McKay R; Thorner AR; Lee GM; Braun DA; Bhatt RS; Freedman M; Choueiri TK; Kwiatkowski DJ
Genet Med; 2020 Aug; 22(8):1366-1373. PubMed ID: 32341571
[TBL] [Abstract][Full Text] [Related]
10. Can circulating cell free DNA be a promising marker in ovarian cancer? - a genome-scale profiling study in a single institution.
Zhou H; Zhang X; Liu Q; Yang J; Bai J; Yin M; Cao D; Zhang Q; Zheng L
J Ovarian Res; 2023 Jan; 16(1):11. PubMed ID: 36641505
[TBL] [Abstract][Full Text] [Related]
11. OvaPrint-A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer.
Buckley DN; Lewinger JP; Gooden G; Spillman M; Neuman M; Guo XM; Tew BY; Miller H; Khetan VU; Shulman LP; Roman L; Salhia B
Clin Cancer Res; 2023 Dec; 29(24):5196-5206. PubMed ID: 37812492
[TBL] [Abstract][Full Text] [Related]
12. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
Yu Z; Qin S; Wang H
J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
[TBL] [Abstract][Full Text] [Related]
13. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of cell-Free DNA methylation profiling with MeDIP-seq identified potential biomarkers for colorectal cancer.
Zhang X; Li T; Niu Q; Qin CJ; Zhang M; Wu GM; Li HZ; Li Y; Wang C; Du WF; Wang CY; Zhao Q; Zhao XD; Wang XL; Zhu JB
World J Surg Oncol; 2022 Jan; 20(1):21. PubMed ID: 35065650
[TBL] [Abstract][Full Text] [Related]
15. Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer.
Bahado-Singh RO; Ibrahim A; Al-Wahab Z; Aydas B; Radhakrishna U; Yilmaz A; Vishweswaraiah S
Sci Rep; 2022 Nov; 12(1):18625. PubMed ID: 36329159
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.
Huang RL; Gu F; Kirma NB; Ruan J; Chen CL; Wang HC; Liao YP; Chang CC; Yu MH; Pilrose JM; Thompson IM; Huang HC; Huang TH; Lai HC; Nephew KP
Epigenetics; 2013 Jun; 8(6):624-34. PubMed ID: 23774800
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Janke F; Angeles AK; Riediger AL; Bauer S; Reck M; Stenzinger A; Schneider MA; Muley T; Thomas M; Christopoulos P; Sültmann H
Clin Epigenetics; 2022 Dec; 14(1):163. PubMed ID: 36461127
[TBL] [Abstract][Full Text] [Related]
19. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study.
Qiao G; Zhuang W; Dong B; Li C; Xu J; Wang G; Xie L; Zhou Z; Tian D; Chen G; Tang J; Zhou H; Zhang D; Shi R; Chen R; Nian W; Zhang Y; Zhao J; Wen X; Xu Y; Li B; Zhang Z; Cai S; Ben X; Qi Y
BMC Med; 2021 Oct; 19(1):243. PubMed ID: 34641873
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
